Actelion Pharmaceuticals Ltd. - Company & Market Research Reports

Actelion Pharmaceuticals develops drugs for pulmonary arterial hypertension treatments that cover the spectrum of diseases ranging from WHO functional class (FC) II through to FC IV, with oral, inhaled, and intravenous medications. Actelion has operative affiliates in over 30 countries. The company was founded in 1997 and is based in Allschwil, Switzerland. Actelion Pharmaceuticals Ltd. operates as a subsidiary of Actelion Ltd.

From
From
From
From
From
From
From
Loading Indicator
adroll